Effect of cigarette smoking on levels of bioavailable testosterone in healthy men
|
|
- Morgan Tyler
- 8 years ago
- Views:
Transcription
1 Clinical Science (2001) 100, (Printed in Great Britain) 661 Effect of cigarette smoking on levels of bioavailable testosterone in healthy men Katherine M. ENGLISH*, Peter J. PUGH*, Helen PARRY*, Nanette E. SCUTT, Kevin S. CHANNER* and T. Hugh JONES *Department of Cardiology, M Floor, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, U.K., Endocrinology and Cardiovasular Research Group, G Floor, Institute of Endocrinology, The Medical School, Beech Hill Road, Sheffield S10 2RX, U.K., and Centre for Diabetes and Endocrinology, Barnsley District General Hospital, Gawber Road, Barnsley, South Yorkshire S75 2EP, U.K. A B S T R A C T The effect of smoking on androgen levels is important given the recent interest in the link between low levels of androgens and the development of cardiovascular disease. Numerous studies examining the effects of cigarette smoking on the levels of total and free testosterone have reported conflicting findings, but there has been no accurate assessment of the effects of cigarette smoking on the levels of bioavailable testosterone [not bound to sex hormone-binding globulin (SHBG)]. We attempted to determine whether smoking affects the level of bioavailable testosterone. We undertook a case-control study of 25 healthy male smokers and 25 healthy never-smokers, matched by age and body mass index. Early morning levels of total, free and bioavailable testosterone, 17β-oestradiol, SHBG and cotinine were determined and compared between the two groups. Levels of total ( nm versus nm, P 0.01) and free testosterone ( pm versus pm, P 0.03) were found to be higher in smokers compared with non-smokers respectively, as was SHBG ( versus nm, P 0.06). There were no significant differences in the levels of bioavailable testosterone ( versus nm, P 0.49) or 17β-oestradiol ( versus pm, P 0.50) between smokers and non-smokers respectively. These data suggest that cigarette smoking has no significant effect on the biologically active fraction of testosterone, but may influence the levels of total and free testosterone through changes in the levels of SHBG. INTRODUCTION The results of previous studies describing the effects of cigarette smoking on testosterone levels in human males have been conflicting, demonstrating that testosterone levels are lower [1,2], similar [3 8] or higher [9 14] in healthy male smokers than in matched non-smokers. However, the effects of cigarette smoking on the levels of bioavailable testosterone are unknown. There is increasing interest surrounding the link between low levels of male sex hormones and coronary artery disease in men. A number of studies have reported lower levels of androgens in cases with coronary heart disease compared with disease-free controls [15], this relationship being particularly marked when the levels of bioavailable testosterone are assessed [16]. The effects of an excess of smokers in groups with coronary artery disease compared with controls in these studies may be an important confounding factor, with the demonstrated differences in levels of testosterone being only a consequence of cigarette smoking, not a risk factor for coronary heart disease itself. Key words: androgens, bioavailable testosterone, coronary artery disease, oestradiol, smoking, testosterone. Abbreviation: SHBG, sex hormone-binding globulin. Correspondence: Dr T. H. Jones, at the Centre for Diabetes and Endocrinology, Barnsley District General Hospital ( hugh.jones bdgh-tr.trent.nhs.uk).
2 662 K. M. English and others The aim of the present study was to determine whether the biologically active fraction of testosterone differs in healthy male smokers and non-smokers, since a significant effect of smoking on androgen levels may confound association studies between levels of testosterone and coronary artery disease. METHODS Study design This was a case-control study undertaken in a teaching hospital with the approval of the local ethics committee. Healthy volunteers were recruited from hospital visitors and staff by posting advertisements in the hospital. Smokers were matched to never-smokers of similar age and body mass index. Subjects were studied between h and h. Subjects A total of 25 male smokers of 10 cigarettes day and 25 males who had never smoked (aged years) were recruited. Volunteers were excluded if they had debilitating illness, diabetes mellitus, a history of infertility or hormone-manipulating therapy. Two cases and one control had mild asthma and two controls had hypertension. Junior doctors were excluded from the study since previous research [17] suggests they may have abnormal androgen levels. Measurements Height and weight were measured, and blood was taken for analysis of levels of serum total testosterone, bioavailable testosterone, sex hormone-binding globulin (SHBG), 17β-oestradiol and cotinine (a metabolite of nicotine). Free testosterone was calculated as a percentage of the total testosterone by a validated method [18], using the formula: % Free testosterone log [SHBG] C-reactive protein was measured to ensure that no subject was suffering from an acute inflammatory illness, which may have affected hormone levels. Total testosterone was measured by RIA (Coat-A- Count; Diagnostic Products Corp., Llanberris, Caernarfon, U.K.). Percentage bioavailable testosterone was assayed using an adaptation of the method of Tremblay and Dube [19], where H-labelled testosterone radioactive tracer was measured in the supernatant fraction following ammonium sulphate precipitation of SHBG. The concentration of bioavailable testosterone was then calculated from the percentage of the total steroid. Interassay variation was less than 8% throughout the range of the assay. SHBG was measured by automated enzyme immunoassay (Immulite; Diagnostic Products Corporation, Los Angeles, CA, U.S.A.). 17β-Oestradiol was measured using an ELISA assay from DRG Instruments GmbH, Germany. Cotinine was measured using the Cozart serum cotinine microplate enzyme immunoassay (Cozart Bioscience Ltd, Abingdon, Oxford, U.K.), to ensure accuracy of the self-reported smoking nonsmoking status of our subjects [20]. C-reactive protein was measured using the high-sensitivity Biostat Diasys kit. Statistical analysis We estimated a sample size requirement of 25 people in each group in order to demonstrate a difference of at least one S.D. in androgen levels with 90% power and 5% significance. Data were inspected and analysed using the SPSS for Windows 95 computer package. Values for all parameters proved to be normally distributed except those for alcohol intake. Student s independent samples t test was used to compare mean values between the two groups for parametric data. The Mann Whitney U test was used to analyse non-parametric data. Correlation coefficients were determined using Pearson s correlation statistic for parametric data. All results are expressed as means S.D. unless otherwise stated. Statistical significance was accepted when P RESULTS Baseline characteristics of the two groups are shown in Table 1. Cases were matched with controls for age and body mass index. Smokers had higher alcohol intake than controls, but this difference was not statistically significant. The large difference in cotinine levels demonstrates the reliability of the self-reported smoking non-smoking status of our subjects. Table 2 shows the hormone profiles of the two groups. Levels of total and free testosterone were significantly higher in smokers compared with non-smokers; however, the more accurate assessment of biologically active androgen status, bioavailable testosterone, was not significantly different. SHBG was higher in smokers than in non-smokers; this difference approached statistical significance. There was no difference in 17β-oestradiol levels between the two groups. Serum cotinine levels correlated positively with the reported number of cigarettes smoked daily (r 0.40, P 0.05) and with levels of SHBG (r 0.49, P 0.05), but not with any of the hormone levels analysed. None of the subjects had raised C-reactive protein, suggestive of concurrent acute inflammatory illness.
3 Smoking and bioavailable testosterone 663 Table 1 Baseline characteristics of smokers and non-smokers Results are expressed as means S.D. Smokers Non-smokers P value Age (years) Body mass index (kg/m 2 ) Cotinine (ng/ml) Alcohol intake (units/week) Table 2 Hormone levels in smokers and non-smokers Results are expressed as means S.D. Abbreviation: nr, normal range. Smokers Non-smokers P value Bioavailable testosterone (nm) (nr 2.5) Free testosterone (pm) (nr ) Total testosterone (nm) (nr ) β-Oestradiol (pm) (nr 150) SHBG (nm) (nr 15 75) DISCUSSION The higher incidence of ischaemic heart disease in men compared with women, and reports of sudden cardiovascular death amongst male athletes abusing anabolic steroids, have led many to assume that androgens are detrimental to the male cardiovascular system [21,22]. However, there is no direct evidence to support this theory, and there are numerous studies to support the contrary view. It has been convincingly demonstrated in male animal models that low androgen levels are associated with an increase in atheroma development, a phenomenon which is reversed by the administration of physiological levels of androgens [23 25]. In addition, a number of case-control studies have described an association between low androgen levels and excess cardiovascular risk in human males [15,26 28]. This relationship is particularly marked when the bioavailable fraction of testosterone is assessed [16]. However, it is well recognized that case-control studies may be easily confounded by other factors. The effects of an excess of smokers in groups with coronary artery disease compared with controls in these studies may be an important confounding factor, with the demonstrated differences in levels of testosterone being only a consequence of cigarette smoking, not a risk factor for coronary heart disease itself. Previous work looking at the effects of smoking on androgen levels has produced conflicting results, which may be explained, in part, by difficulties in the accurate assessment of testosterone levels. Androgens display marked circadian fluctuations in plasma levels, and considerable intra- and inter-individual variability. In addition, much (65 80%) of the circulating total testosterone is inactive and tightly bound to SHBG, whereas the biologically active fraction circulates either free (1 3%) in the circulation or loosely bound (20 35%) to albumin [29]. Levels of total testosterone can, therefore, be directly affected by changes in levels of SHBG and other plasma proteins. In addition, the direct immunoassay techniques used most commonly to measure free testosterone are also subject to variation due to differences in SHBG level [30]. Thus the measurement of total or free testosterone alone is insufficient to accurately assess the true impact of smoking on biologically active androgen status. Two previous studies [1,2] demonstrated significant falls in the levels of total testosterone amongst male smokers compared with non-smokers, but the levels of free, bioavailable testosterone, oestradiol or SHBG were not assessed in these patients. Conversely, many other studies [9 14] have found the levels of total testosterone to be increased amongst male smokers. Two of these studies [10,14] also reported an increase in the levels of free testosterone. However, in all but one of these studies [9], no measurement of SHBG was made, and hence the testosterone levels were not adjusted for differences in plasma protein binding. The one study which did measure SHBG [9] demonstrated a significant increase in SHBG, but no significant change in albumin-bound testosterone, suggesting the raised total testosterone levels were secondary to the raised SHBG. This is the only previous study to measure albumin-bound testosterone, an approximation of the bioavailable fraction, and no significant difference was seen. Finally, a number of studies [3 8] have reported no significant differences in the levels of total or free testosterone in male smokers versus non-smokers.
4 664 K. M. English and others The present study demonstrates that plasma levels of biologically active testosterone, as assessed by the levels of bioavailable testosterone, do not differ between healthy male smokers and non-smokers, whereas levels of total and free testosterone are significantly higher in smokers. This discrepancy is a reflection of the difference in SHBG, which was higher in the smokers than in nonsmokers. We have also demonstrated that there was no significant difference in 17β-oestradiol levels, suggesting that the increased SHBG in the smokers is independent of changes in 17β-oestradiol levels. SHBG was the only variable which significantly correlated with serum cotinine levels, a measure of cigarette smoking. This may indicate that smoking has a greater relative effect on the levels of SHBG than on the hormones themselves, supporting the suggestion that the observed differences in total and free testosterone in this and previous studies are due to changes in plasma binding capacity, rather than an effect of smoking on androgen levels. Plasma levels of SHBG may also be influenced by other clinical factors. Thyrotoxicosis and liver cirrhosis are both associated with elevated SHBG levels, whereas hypothyroidism and obesity have been linked with decreased SHBG levels [31,32]. Although thyroid and liver function tests were not performed in this study, there was no clinical suspicion of thyroid or liver disease in any subject. Furthermore, subjects were matched by body mass index (Table 1). We conclude that accurate assessment of androgen status should include a measure of the biologically active fraction. In addition, it appears that smoking has no significant effect on the levels of bioavailable testosterone, and causes an increase in the measured levels of total testosterone. There is no evidence to suggest, therefore, that smoking status may be a confounding factor in association studies demonstrating a link between low levels of androgens and coronary heart disease. ACKNOWLEDGMENTS We thank Dr Mike Diver, University of Liverpool, for performing the bioavailable testosterone assays, and Mr Martin Loxley, Department of Clinical Chemistry, Royal Hallamshire Hospital, Sheffield, for his expert help in performing the SHBG and total testosterone assays. REFERENCES 1 Briggs, M. H. (1973) Cigarette smoking and infertility in men. Med. J. Aust. 1, Shaarawy, M. and Mahmoud, K. Z. (1982) Endocrine profile and semen characteristics in male smokers. Fertil. Steril. 38, Klaiber, E. L. and Broverman, D. M. (1988) Dynamics of estradiol and testosterone and seminal fluid indexes in smokers and non-smokers. Fertil. Steril. 50, Hautanen, A., Manttari, M., Kupari, M. et al. (1993) Cigarette smoking is associated with elevated adrenal androgen response to adrenocorticotropin. J. Steroid. Biochem. Mol. Biol. 46, Barrett-Connor, E. and Khaw, K.-T. (1987) Cigarette smoking and increased endogenous estrogen levels in men. Am. J. Epidemiol. 126, Lindholm, J., Winkel, P., Brodthagen, U. and Gyntelberg, F. (1982) Coronary risk factors and plasma sex hormones. Am. J. Med. 73, Meikle, A. W., Bishop, D. T., Stringham, J. D., Ford, M. H. and West, D. W. (1987) Cigarette smoking alters plasma sex-steroid levels. Clin. Res. 35, 183A 8 Handelsman, D. J., Conway, A. J., Boylan, L. M. and Turtle, J. R. (1984) Testicular function in potential sperm donors: normal ranges and the effects of smoking and varicocele. Int. J. Androl. 7, Field, A. E., Colditz, G. A., Willett, W. C., Longcope, C. and McKinlay, J. B. (1994) The relation of smoking, age, relative weight and dietary intake to serum adrenal steroids, sex hormones and sex hormone-binding globulin in middle-aged men. J. Clin. Endocrinol. Metab 79, Handa, K., Ishii, H., Kono, S. et al. (1997) Behavioural correlates of plasma sex hormones and their relationships with plasma lipids and lipoproteins in Japanese men. Atherosclerosis 130, Vogt, H. J., Heller, W. D. and Borelli, S. (1986) Sperm quality of healthy smokers, ex-smokers, and never smokers. Fertil. Steril. 45, Attia, A. M., El-Dakhly, M. R., Halawa, F. A., Ragab, N. F. and Mossa, M. M. (1989) Cigarette smoking and male reproduction. Arch. Androl. 23, Deslypere, J. P. and Vermeulen, A. (1984) Leydig cell function in normal men: effect of age, lifestyle, residence, diet and activity. J. Clin. Endocrinol. Metab. 59, Dai, W. S., Gutai, J. P., Kuller, L. H. and Cauley, J. A. (1988) Cigarette smoking and serum sex hormones in men. Am. J. Epidemiol. 128, Alexandersen, P., Haarbo, J. and Christiansen, C. (1996) The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 125, English, K. M., Mandour, O., Steeds, R. P., Diver, M. J., Jones, T. H. and Channer, K. S. (2000) Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur. Heart. J. 21, Singer, F. and Zumoff, B. (1992) Subnormal serum testosterone levels in male internal medicine residents. Steroids 57, Nanjee, M. N. and Wheeler, M. J. (1985) Plasma free testosterone is an index sufficient? Ann. Clin. Biochem. 22, Tremblay, R. R. and Dube, J. Y. (1974) Plasma concentrations of free and non Te-BG bound testosterone in women on oral contraceptives. Contraception 10, Smith, R. F., Mather, H. M. and Ellard, G. A. (1998) Assessment of simple colorimetric procedures to determine smoking status of diabetic subjects. Clin. Chem. 44, British Heart Foundation Statistics Database (1996) British Heart Foundation 22 Sullivan, L., Martinez, C. M., Gennis, P and Gallagher, E. J. (1998) The cardiac toxicity of anabolic steroids. Prog. Cardiovasc. Dis. 41, Alexandersen, P., Haarbo, J., Byrjalsen, I., Lawaetz, H. and Christiansen, C. (1999) Natural androgens inhibit male atherosclerosis: A study in castrated, cholesterol fed rabbits. Circ. Res. 84, Larsen, B. A., Nordestgaard, B. G., Stender, S. and Kjeldsen, K. (1993) Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels. Atherosclerosis 99, Bruck, B., Brehme, U., Gugel, N. et al. (1997) Gender specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 17,
5 Smoking and bioavailable testosterone Herrington, D. M. (1995) Dehydroepiandrosterone and coronary atherosclerosis. Ann. N.Y. Acad. Sci. 774, Wu, S. Z. and Weng, X. Z. (1993) Therapeutic effects of an androgenic preparation on myocardial ischaemia and cardiac function in 62 elderly male coronary heart disease patients. Chin. Med. J. 106, Zhao, S. P. and Li, X. P. (1998) The association of low plasma testosterone level with coronary artery disease in Chinese men. Int. J. Cardiol. 63, Dunn, J. F., Nisula, B. C. and Rodbard, D. (1981) Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid binding globulin in human plasma. J. Clin. Endocrinol. Metab. 53, Vermeulen, A., Verdonck, L. and Kaufman, J. M. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, Rosner, W. (1990) The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 11, von Schoultz, B. and Carlstrom, K. (1989) On the regulation of sex-hormone-binding globulin a challenge of an old dogma and outlines of an alternative mechanism. J. Steroid. Biochem. 32, Received 5 January 2001/8 February 2001; accepted 22 March 2001
TESTOSTERONE (T) circulates in plasma nonspecifically
0021-972X/99/$03.00/0 Vol. 84, No. 10 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 1999 by The Endocrine Society A Critical Evaluation of Simple Methods for the Estimation
More informationSerum testosterone and short-term mortality in men with acute myocardial infarction
ORIGINAL ARTICLE Cardiology Journal 2010, Vol. 17, No. 3, pp. 249 253 Copyright 2010 Via Medica ISSN 1897 5593 Serum testosterone and short-term mortality in men with acute myocardial infarction Constantin
More informationMEASUREMENT OF TESTOSTERONE Roland R. Tremblay
MEASUREMENT OF TESTOSTERONE Roland R. Tremblay Learning Objectives 1. To understand that andropause is constituted by two structural levels and that the surface structure is amenable to diagnosis and treatment.
More informationThe Relationship Between Low Testosterone and Cardiovascular Disease
Testosterone and Cardiovascular Risk in Men Daniel M. Kelly a T. Hugh Jones a, b a Department of Human Metabolism, Medical School, The University of Sheffield, Sheffield, and b Centre for Diabetes and
More informationCalcium. Table 1: Difference between method means in percent
Calcium Measurement of total calcium is widely used for both the diagnosis and the monitoring of a range of conditions related to the bones, heart, nerves, and kidneys. Total calcium measurements include
More informationInternational Journal of Pharma and Bio Sciences RELATIONSHIP OF TESTOSTERONE LEVELS IN MALES WITH CORONARY HEART DISEASE
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE BIO CHEMISTRY RELATIONSHIP OF TESTOSTERONE LEVELS IN MALES WITH CORONARY HEART DISEASE MAMTA SETH *1, ASHUMA SACHDEVA 2, PRASANTA SAHAROY
More informationFree Testosterone Cat# 2924Z
See external label 2 C-8 C Σ=96 tests Cat # 2924Z Free Testosterone Cat# 2924Z Direct immunoenzymatic determination of Free Testosterone in serum or plasma. For in vitro diagnostic use only INTENDED USE
More informationFocus. Andropause: fact or fiction? Introduction. Johan Wilson is an Auckland GP KEY POINTS
1 of 5 Focus Andropause: fact or fiction? Johan Wilson is an Auckland GP Introduction Androgen deficiency in the ageing male, or andropause, is being diagnosed with increased frequency. A growing body
More informationCurrent Data and Considerations Novel Testosterone Formulations
Current Data and Considerations Novel Testosterone Formulations 1 Diagnosis and Assessment Module 2 2 Objectives Identify clinical manifestations and symptoms of hypogonadism Describe components of comprehensive
More informationFACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN
FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN General Pantarhei Bioscience B.V. is an emerging specialty pharmaceutical company with a creative approach towards drug development. The Company
More informationCardiovascular Disease in Men
539 Endogenous Sex Hormones and Cardiovascular Disease in Men A Prospective Population-Based Study Elizabeth Barrett-Connor, MD, and Kay-Tee Khaw, MRCP, MSc Plasma obtained and frozen in 1972-1974 from
More informationSex Hormone Testing by Mass Spectrometry
Sex Hormone Testing by Mass Spectrometry Robert L. Fitzgerald, PhD, DABCC Professor of Pathology University of California-San Diego San Diego, CA, 92161 rfitzgerald@ucsd.edu Learning Objectives After this
More informationTestosterone and Heart Disease
Testosterone and Heart Disease By Pamela W. Smith, M.D., MPH, MS Introduction Two recent trials suggest that testosterone replacement therapy may increase the risk of heart disease and/or stroke. 1, 2
More informationAre Men Losing Their Gonads?
Are Men Losing Their Gonads? Andre B. Araujo, Ph.D. Director, Epidemiology New England Research Institutes Watertown, MA 02472 USA aaraujo@neriscience.com NIA R01AG020727 Endocrine Society Annual Meeting
More informationMen Sexual Dysfunction Associated with Obesity and Metabolic Syndrome
Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome By Aly A. Abbassy, MD, FACE Professor of Medicine (Endocrinology) Alexandria University My Talk will include: 1-Types of Men sexual
More informationHypogonadism and Testosterone Replacement in Men with HIV
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Hypogonadism and Testosterone Replacement in Men with HIV Stephanie T. Page, MD, PhD Robert B. McMillen Professor in Lipid Research, Associate Professor of
More informationPlasma Testosterone Level in Male Patients with Metabolic Syndrome
Med. J. Cairo Univ., Vol. 77, No. 1, June: 351-357, 2009 www.medicaljournalofcairouniversity.com Plasma Testosterone Level in Male Patients with Metabolic Syndrome NASHWA EL-SARRAF, M.D. and AMR EL-HADIDY,
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationThe Role of Albumin in the Calculation of Free and Bioavailable Testosterone in Women with Hyperandrogenemia
The Role of Albumin in the Calculation of Free and Bioavailable Testosterone in Women with Hyperandrogenemia ANDREAS MUELLER, SUSANNE CUPISTI, HELGE BINDER, INGE HOFFMANN, MATTHIAS W. BECKMANN and RALF
More informationTHE ROLE OF FREE TESTOSTERONE COMPARATIVE WITH TOTAL TESTOSTERONE IN MALE PATIENTS WITH ERECTILE DYSFUNCTION
THE ROLE OF FREE TESTOSTERONE COMPARATIVE WITH TOTAL TESTOSTERONE IN MALE PATIENTS WITH ERECTILE DYSFUNCTION Porav-Hodade Daniel 1, Coman Ioan 2, Boja Radu M 1, Todea Ciprian 1, Georgescu Carmen 2, Crisan
More informationThe ABC s and T s of Male Infertility
The ABC s and T s of Male Infertility Men s Health Initiative of BC - Focus on Testosterone Ethan D. Grober, MD, MEd, FRCSC Assistant Professor University of Toronto Department of Surgery, Division of
More informationTestosterone and androgens in women
Testosterone and androgens in women http://womenshealth.med.monash.edu.au 1. Women normally produce testosterone 2. Changes in testosterone over the normal menstrual cycle 3. Changes in testosterone with
More informationAge Management Panel Male Fasting Panel
801 SW 16th St Suite 126 Renton WA 98057 Phone: 425.271.8689 Fax: 425.271.8689 CLIA # 50D0630590 Age Management Panel Male Fasting Panel Doctor ID 1001 Age 55 Date Collected 01/01/07 Patient Name DOE,
More informationAssociation of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization
Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization Robert L. Barbieri, M.D., a Pat M. Sluss, M.D., b Robert D.
More informationUs TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy
Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Today s speaker is Samir Taneja, MD Program moderator is Pam Barrett, Us TOO International Made possible
More informationContinuity Clinic Educational Didactic. December 8 th December 12 th
Continuity Clinic Educational Didactic December 8 th December 12 th MKSAP Question 1 A 60-year-old man is evaluated for a 1-year history of generalized fatigue and lack of energy. He has had erectile dysfunction
More informationTestosterone and coronary heart disease: is there a link?
Q) Med 1997; 90:787-791 Commentary QJM Testosterone and coronary heart disease: is there a link? K.M. ENGLISH, R. STEEDS, T.H. JONES 1 and K.S. CHANNER From the Departments of Cardiology and ^ Endocrinology,
More informationVaricocele: To Fix or Not to Fix? That is the Question. Edmund S. Sabanegh, MD
Varicocele: To Fix or Not to Fix? That is the Question. Edmund S. Sabanegh, MD Professor and Chairman, Department of Urology, Cleveland Clinic Lerner College of Medicine; Cleveland, Ohio Objectives: Review
More informationCommon Endocrine Disorders. Gary L. Horowitz, MD Beth Israel Deaconess Medical Center Boston, MA
Common Endocrine Disorders Gary L. Horowitz, MD Beth Israel Deaconess Medical Center Boston, MA Objectives Describe the typical laboratory values for TSH and Free T4 in hypo- and hyperthyroidism Explain
More informationCoronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
More informationTestosterone for women, who when and how much?
Medicine, Nursing and Health Sciences Testosterone for women, who when and how much? Susan R Davis MBBS FRACP PhD Women s Health Research Program School of Public Health Monash University Melbourne Medicine,
More informationTestosterone: Is Just for the GOP?
Testosterone: Is Just for the GOP? Brad Anawalt, MD Vice Chair and Professor of Medicine University of Washington May 1, 2015 banawalt@medicine.washington.edu Testosterone continuum Severe hypogonadism
More informationMichael L. DeVan, 1 Daniel D. Bankson, 2 and Jude M. Abadie 1. Abstract
Clinical Chemistry / Measurable Free Testosterone Levels To What Extent Are Free Testosterone (FT) Values Reproducible Between the Two Washingtons, and Can Calculated FT Be Used in Lieu of Expensive Direct
More informationAndrogens and CVD. Brandon Orr- Walker April 2014
Androgens and CVD Brandon Orr- Walker April 2014 Agenda What is normal physiology of Aging? Hypogonadism and disease If some is good is more becer? CVD safety Clinical features of Androgen Deficiency
More informationSerum Testosterone Levels and Arterial Blood Pressure in the Elderly
625 Original Article Hypertens Res Vol.28 (2005) No.8 p.625-630 Serum Testosterone Levels and Arterial Blood Pressure in the Elderly Roberto FOGARI, Paola PRETI, Annalisa ZOPPI, Elena FOGARI, Andrea RINALDI,
More informationFunctional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE
Functional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE Interpretation and treatment: male hormone profile By Ron Grisanti, D.C. & Dicken Weatherby, N.D. http://www.functionalmedicineuniversity.com
More informationPrevalence and Characteristics of Low Serum Testosterone Levels in Men with Type 2 Diabetes Mellitus Naïve to Injectable Therapy
Prevalence and Characteristics of Low Serum Testosterone Levels in Men with Type 2 Diabetes Mellitus Naïve to Injectable Therapy International Society for Sexual Medicine 2014 Presenter: Felipe Borges
More informationCardiovascular Disease Risk Factors
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
More informationRole of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
More informationMENOPAUSE WOMAN'S TEST (Assessment of hormone balance)
ATTACHMENT: Useful remarks for patient and doctor, to be associated to the analytical results. Your doctor should interpret this report. Cod. ID: 123456 CCV: 6bf Date: 01/01/2013 Patient: Rossi Mario Rapport
More informationPrognostic impact of uric acid in patients with stable coronary artery disease
Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME
1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL SEMINAR INSULIN RESISTANCE, POLYCYSTIC OVARIAN
More information4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH
METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?
More informationEducation. Panel. Triglycerides & HDL-C
Triglycerides & HDL-C Thomas Dayspring, MD, ACP Clinical Assistant Professor of Medicine University of Medicine and Dentistry of New Jersey Attending in Medicine: St Joseph s s Hospital, Paterson, NJ Certified
More informationMale Health. The three major issues are: Cardiovascular Health Prostate Health Fertility & Sexual Performance
Male Health Do Men Value Their Health? The ancient Greek physician Hippocrates once said, A wise man ought to realise that his health is his most valuable possession. It is believed that Hippocrates lived
More informationAppendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
More informationListen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationValidity of Free Testosterone and Free Estradiol Determinations in Serum Samples from Postmenopausal Women by Theoretical Calculations
Vol. 11, 1065 1071, October 2002 Cancer Epidemiology, Biomarkers & Prevention 1065 Validity of Free Testosterone and Free Estradiol Determinations in Serum Samples from Postmenopausal Women by Theoretical
More informationFree Testosterone. Cat# 2924Z. Direct immunoenzymatic determination of Free Testosterone in serum or plasma. Free Testosterone ELISA Method
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationtestosterone_pellet_implantation_for_androgen_deficiency_in_men 10/2015 N/A 11/2016 10/2015 This policy is not effective until December 30, 2015
Corporate Medical Policy Testosterone Pellet Implantation for Androgen Deficiency in File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testosterone_pellet_implantation_for_androgen_deficiency_in_men
More informationBIOCHEMICAL TESTS FOR THE INVESTIGATION OF COMMON ENDOCRINE PROBLEMS IN THE MALE
Authoriser: Moya O Doherty Page 1 of 7 BIOCHEMICAL TESTS FOR THE INVESTIGATION OF COMMON ENDOCRINE PROBLEMS IN THE MALE The purpose of this protocol is to describe common tests used for the investigation
More informationTestosterone Treatment in Older Men
Testosterone Treatment in Older Men J. Bruce Redmon, M.D. Professor Division of Endocrinology Departments of Medicine and Urologic Surgery Disclosure Information I have no financial relationships to disclose.
More informationDiurnal variation of testosterone (T) has been well documented
ORIGINAL ARTICLE Endocrine Care The Effect of Diurnal Variation on Clinical Measurement of Serum Testosterone and Other Sex Hormone Levels in Men Donald J. Brambilla, Alvin M. Matsumoto, Andre B. Araujo,
More informationAssessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study
European Journal of Clinical Investigation (2007) 37, 925 932 DOI: 10.1111/j.1365-2362.2007.01888.x Blackwell Publishing Ltd Review Assessing risk of myocardial infarction and stroke: new data from the
More informationANDROPAUSE. Male Menopause
Male Menopause Male Hormones and Aging As men age past year 40, hormonal changes occur that perceptibly inhibit physical, sexual, and cognitive function. The outward appearance of a typical middle-aged
More informationEndocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER
Endocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER 80% of children and adults with FA have an endocrine abnormality Endocrine cells make a hormone (message) Carried in bloodstream
More informationTestosterone Treatment: Myths Vs Reality. Fadi Al-Khayer, M.D, F.A.C.E
Testosterone Treatment: Myths Vs Reality Fadi Al-Khayer, M.D, F.A.C.E The Biological Functions of Testosterone in Men Testosterone is essential to the musculoskeletal and metabolic systems throughout a
More informationProtein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
More informationDeficient testosterone levels in men above 45 years with major depressive disorder an age-matched case control study
Deficient testosterone levels in men above 45 years with major depressive disorder an age-matched case control study A M Dikobe, MB ChB, MMed (Psych) C W van Staden, MB ChB, MMed (Psych), MD, FCPsych,
More informationTestosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome
european urology supplements 6 (2007) 847 857 available at www.sciencedirect.com journal homepage: www.europeanurology.com Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic
More informationShira Miller, M.D. Los Angeles, CA 310-734-8864 www.shiramillermd.com. The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library
Shira Miller, M.D. Los Angeles, CA 310-734-8864 The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library 2 Outline What is hormone therapy? Why would healthy men and women need to think about
More informationFree Testosterone ELISA
Instructions for use Free Testosterone ELISA AA E-1400 Free Testosterone ELISA INTENDED USE For the direct quantitative determination of Free Testosterone by enzyme immunoassay in human serum. For in vitro
More informationHEALTH UPDATE. Polycystic Ovary Syndrome (PCOS)
HEALTH UPDATE PO Box 800760 Charlottesville, VA 22908 Gynecology: (434) 924-2773 Polycystic Ovary Syndrome (PCOS) What is it? An endocrine (hormonal) disorder. Because there is such variability in how
More informationAsian J Androl 2008; 10 (2): 193 200
Asian J Androl 2008; 10 (2): 193 200 DOI: 10.1111/j.1745-7262.2008.00332.x www.asiaandro.com. Original Article. Higher testosterone levels are associated with increased highdensity lipoprotein cholesterol
More informationOriginal Article INTRODUCTION. Wan Chul Lee 1, Ma Tae Kim 1, Kyung Tae Ko 1, Won Ki Lee 2, Sung Yong Kim 1, Ha Young Kim 1, Dae Yul Yang 1
pissn: 2287-4208 / eissn: 2287-4690 World J Mens Health 2014 December 32(3): 139-144 http://dx.doi.org/10.5534/wjmh.2014.32.3.139 Original Article Relationship between Serum Testosterone and Cardiovascular
More informationEvaluation of Androgen Levels in Patients with Acute Coronary Syndrome
Evaluation of Androgen Levels in Patients with Acute Coronary Syndrome Fatma Dilek Dellal 1, Mutlu Niyazoğlu 2, Tamer Çeviker 3, Süheyla Görar 4, Ertuğrul Taşan 5 1 Endocrinology, Agri Government Hospital,
More informationPlease use only the valid version of the package insert provided with the kit.
Please use only the valid version of the package insert provided with the kit. 1 INTENDED USE For the direct quantitative determination of Free Testosterone by enzyme immunoassay in human serum. For in
More informationRelation of Serum Testosterone Levels to High Density Lipoprotein Cholesterol and Other Characteristics in Men
37 Relation of Serum Testosterone Levels to High Density Lipoprotein Cholesterol and Other Characteristics in Men David S. Freedman, Thomas R. O'Brien, W. Dana Flanders, Frank DeStefano, and Joseph J.
More informationFebruary 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS
February 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS Calvin Hirsch, MD Professor of Clinical Internal Medicine (Geriatrics) UC Davis School of
More informationMale New Patient Package
Male New Patient Package The contents of this package are your first step to restore your vitality. Please take time to read this carefully and answer all the questions as completely as possible. Thank
More informationPrevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus
Prevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus Hypogonadism is defined as deficient or absent male gonadal function
More informationAnnals of Oncology Advance Access published October 13, 2010
Advance Access published October 13, 2010 doi:10.1093/annonc/mdq565 Maternal and cord blood hormone levels in the United States and China and the intrauterine origin of breast cancer P. Lagiou 1,2, E.
More informationINFERTILITY/POLYCYSTIC OVARIAN SYNDROME. Ovulatory Dysfunction: Polycystic ovarian syndrome (PCOS)
Introduction Infertility is defined as the absence of pregnancy following 12 months of unprotected intercourse. Infertility may be caused by Ovulatory Dysfunction, Blocked Fallopian Tubes, Male Factor
More informationTestosterone and Growth Hormone: Use and Misuse in Sports
Clinical Concerns Testosterone and Growth Hormone: Use and Misuse in Sports Donald W. Morrish, MD, PhD, FRCPC Presented at the University of Alberta s 2nd Biennial Mountain Man (Men s Health) Conference,
More informationVitamin D and Cardiometabolic risk
Vitamin D and Cardiometabolic risk 서울의대, 분당서울대병원 내과 최 성 희 2013년 대한당뇨병학회 춘계학술대회 Metabolism Of Vitamin D Risk factors for vitamin D deficiency - Aging decreased concentrations of 7-dehydro-cholesterol in
More informationCholesterol and Triglycerides What You Should Know
Cholesterol and Triglycerides What You Should Know Michael T. McDermott MD Professor of Medicine Endocrinology Practice Director Division of Endocrinology, Metabolism and Diabetes University of Colorado
More informationRelationship of Hemoglobin A1c to Mortality in Nonsmoking Insurance Applicants
JOURNAL OF INSURANCE MEDICINE Copyright E 2007 Journal of Insurance Medicine J Insur Med 2007;39:174 181 MORTALITY Relationship of Hemoglobin A1c to in Nonsmoking Insurance Applicants Robert L. Stout,
More informationShort Synacthen Test for the Investigation of Adrenal Insufficiency
Pathology at the Royal Derby Hospital Short Synacthen Test Standard Clinical Guidelines Chemical Pathology Department Valid Until 31 st March 2015 Document Code: CHISCG1 Short Synacthen Test for the Investigation
More informationEndocrine Responses to Resistance Exercise
chapter 3 Endocrine Responses to Resistance Exercise Chapter Objectives Understand basic concepts of endocrinology. Explain the physiological roles of anabolic hormones. Describe hormonal responses to
More informationBlood Testing Protocols. Disclaimer
Blood Testing Protocols / Page 2 Blood Testing Protocols Here are the specific test protocols recommend by Dr. J.E. Williams. You may request these from your doctor or visit www.readyourbloodtest.com to
More informationCOULD IT BE LOW TESTOSTERONE?
COULD IT BE LOW TESTOSTERONE? By Dr. Lauren M. Bramley For thousands of years women have been recognized for their sensitivity to hormones. PMS, post partum depression, menopause have long been plights
More informationPREFERRED UNDERWRITING CLASSIFICATIONS
PREFERRED UNDERWRITING CLASSIFICATIONS term ADVISOR GUIDE ABOUT EQUITABLE LIFE OF CANADA Equitable Life is one of Canada s largest mutual life insurance companies. For generations we ve provided policyholders
More informationSmoking and Erectile Dysfunction
Information for patients Smoking and Erectile Dysfunction Royal Hallamshire Hospital How do you get an erection? When you have romantic or sexual thoughts, signals are sent from your brain to the nerves
More informationUsing Family History to Improve Your Health Web Quest Abstract
Web Quest Abstract Students explore the Using Family History to Improve Your Health module on the Genetic Science Learning Center website to complete a web quest. Learning Objectives Chronic diseases such
More informationELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits
VI: 2 ELEMENTS FOR A PUBLIC SUMMARY Bicalutamide (CASODEX 1 ) is a hormonal therapy anticancer agent, used for the treatment of prostate cancer. Hormones are chemical messengers that help to control the
More informationWhat is a Heart Attack? 1,2,3
S What is a Heart Attack? 1,2,3 Heart attacks, otherwise known as myocardial infarctions, are caused when the blood supply to a section of the heart is suddenly disrupted. Without the oxygen supplied by
More informationGARY S. DONOVITZ, M.D., F.A.C.O.G.
Sub-Cutaneous Hormone Pellet Therapy- The Comprehensive Treatment to Optimize and Balance Hormones Using the BioTE Method GARY S. DONOVITZ, M.D., F.A.C.O.G. The BioTE method of hormone replacement is a
More information3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%
S What is Heart Failure? 1,2,3 Heart failure, sometimes called congestive heart failure, develops over many years and results when the heart muscle struggles to supply the required oxygen-rich blood to
More informationAlbumin and All-Cause Mortality Risk in Insurance Applicants
Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH
More informationThe WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?
AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division
More informationCardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone
James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest
More informationAge-related testosterone decline in a Brazilian cohort of healthy military men
Clinical Urology International Braz J Urol Vol. 37 (5): 591-597, September - October, 2011 Age-related testosterone decline in a Brazilian cohort of healthy military men Archimedes Nardozza Júnior, Sérgio
More informationPrimary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care
Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care This advice has been developed to help GPs with shared care of patients with Non- Alcohol
More informationBMC Med 7/19/2007; Simvastatin linked to reduced incidence of dementia, Parkinson s disease.
March 3, 2012 BD Response to FDA statement regarding Statins The Food and Drug Administration announced on Tuesday (February 28, 2012) the changes to the safety information on the labels of statins regarding
More informationNeal Rouzier responds to the JAMA article on Men and Testosterone
Neal Rouzier responds to the JAMA article on Men and Testosterone On the first day the JAMA article was released I received 500 emails from physicians and patients requesting my opinion of the article
More informationHôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires
Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires Prof. J. Philippe Effect of estrogens on glucose metabolism : Fasting Glucose, HbA1c and C-Peptide
More informationUPLC/MSMS in the analysis of physiological steroids. May 2012. Anders Feldthus. Anders_Feldthus@Waters.com. 2012 Waters Corporation 1
UPLC/MSMS in the analysis of physiological steroids Anders Feldthus Anders_Feldthus@Waters.com May 2012 2012 Waters Corporation 1 Clinical Chemistry Mass Spectrometry Citations (1955-2006) 70 Number of
More informationAging Well - Part V. Hormone Modulation -- Growth Hormone and Testosterone
Aging Well - Part V Hormone Modulation -- Growth Hormone and Testosterone By: James L. Holly, MD (The Your Life Your Health article published in the December 4th Examiner was a first draft. It was sent
More information